Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis

Clin Case Rep. 2020 May 25;8(8):1337-1339. doi: 10.1002/ccr3.2915. eCollection 2020 Aug.

Abstract

Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2-mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata.

Publication types

  • Case Reports